Literature DB >> 3619221

Recovery from steroid-induced osteoporosis.

N A Pocock, J A Eisman, C R Dunstan, R A Evans, D H Thomas, N L Huq.   

Abstract

The reversibility of steroid-induced osteoporosis, a major complication of Cushing syndrome and long-term use of exogenous corticosteroids, is not well documented. We measured the bone mineral density of lumbar vertebras and the femoral neck by dual-photon absorptiometry and determined the biochemical variables of bone turnover in two patients successfully treated for Cushing syndrome who were followed for the next 24 months. Our data are the first to show marked increases in bone density (up to 20%) during the recovery period. The accompanying biochemical changes, particularly the marked increase in serum osteocalcin levels, confirm that enhanced bone formation occurred during the recovery phase. These findings suggest that steroid-induced osteoporosis can be reversed at least in young persons.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619221     DOI: 10.7326/0003-4819-107-2-319

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  21 in total

Review 1.  Bone loss and glucocorticoid therapy in patients with respiratory disease.

Authors:  A Fairney
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Management of bone disease in patients on long term glucocorticoid therapy.

Authors:  J E Compston
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

3.  One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density.

Authors:  J A Hughes; B G Conry; S M Male; R Eastell
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 4.  Corticosteroids and osteoporosis.

Authors:  R Smith
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

5.  Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: prospective study.

Authors:  Akiko Kawamata; Masatoshi Iihara; Takahiro Okamoto; Takao Obara
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

6.  Bone histomorphometry in Cushing's syndrome.

Authors:  A Borelli; M O Leite; P H Correa; V Jorgetti; J A Marcondes; J R Batalha; A B Cintra; B L Wajchenberg
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

Review 7.  Impact of bone mineral measurements on osteoporosis.

Authors:  I Fogelman; A Rodin; G Blake
Journal:  Eur J Nucl Med       Date:  1990

8.  Use of quantitative ultrasound of the hand phalanges in the diagnosis of two different osteoporotic syndromes: Cushing's syndrome and postmenopausal osteoporosis.

Authors:  V Camozzi; V Carraro; M Zangari; F Fallo; F Mantero; G Luisetto
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

9.  Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome.

Authors:  A Sartorio; A Conti; S Ferrario; E Passini; T Re; B Ambrosi
Journal:  Postgrad Med J       Date:  1996-07       Impact factor: 2.401

10.  Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study.

Authors:  G Haugeberg; B Griffiths; K B Sokoll; P Emery
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.